4761 - 4770 of 8666 Results
Title
Year
-
OPENTitle: β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 357Issue #: 6354Start Page: 891End Page: 898Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.aaf3934Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5761666Citation Count: 403
-
OPENTitle: GP2: The Global Parkinson's Genetics ProgramJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 842End Page: 851Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28494Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28494Citation Count: 129
-
RESTRICTEDTitle: The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid FormationJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 136Issue #: 10Start Page: 3859End Page: 3868Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/ja411577tCitation Count: 238
-
OPENTitle: ggtranscript: an R package for the visualization and interpretation of transcript isoforms usingggplot2Journal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 38Issue #: 15Start Page: 3844End Page: 3846Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/bioinformatics/btac409Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/38/15/3844/49884398/btac409.pdfCitation Count: 309
-
OPENTitle: Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotypeJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 30Issue #: 4Start Page: 1465End Page: 1483Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2022.01.021Best OA location URL: http://www.cell.com/article/S1525001622000211/pdfCitation Count: 15
-
OPENTitle: Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 69Issue #:Start Page: 119End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7061324Citation Count: 35
-
OPENTitle: Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrinaJournal Name: Journal of Extracellular BiologyPublisher: WileyVol: 1Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jex2.59Best OA location URL: https://doi.org/10.1002/jex2.59Citation Count: 104
-
OPENTitle: Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 19Issue #:Start Page: 1025End Page: 1035Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2018.05.006Best OA location URL: https://doi.org/10.1016/j.nicl.2018.05.006Citation Count: 55
-
OPENTitle: The Future of GDNF in Parkinson's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.593572Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.593572/pdfCitation Count: 43
-
OPENTitle: The commercial genetic testing landscape for Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 107End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.001Best OA location URL: http://www.prd-journal.com/article/S1353802021003564/pdfCitation Count: 27